Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

Clinical trial NCT07053904 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07053904
Sponsor: PharmaEssentia
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-04-21
Primary completion: 2028-12-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.